Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital

被引:59
作者
Pegues, DA
Pegues, CF
Hibberd, PL
Ford, DS
Hooper, DC
机构
[1] MASSACHUSETTS GEN HOSP,INFECT DIS UNIT,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,INFECT CONTROL UNIT,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02114
关键词
D O I
10.1128/JCM.35.6.1565-1570.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We prospectively identified patients at the Massachusetts General Hospital from whom vancomycin-resistant enterococci (VRE) were isolated from a clinical specimen from 1 January 1991 through 31 December 1995. VRE strains were available from 139 (82%) of the 169 patients with clinical cases. Of these, 39 (28%) were identical or closely related by pulsed-field gel electrophoresis (i.e., VRE type A strain), including 38 (43%) of 89 VRE strains in 1995. By multivariate analysis, acquisition of the VRE type A strain was associated with receipt of clindamycin (odds ratio [OR] = 10.5), 15 or more days of hospitalization before the first isolation of VRE (OR = 2.9), and residence on one of the general medical floors (OR = 7.8). The VRE type A strain was a vanA strain of Enterococcus faecium and was highly resistant to all antimicrobial agents tested except chloramphenicol. These findings document the rapid dissemination of a highly resistant strain of E. faecium among patients and among other extant VRE strains at the Massachusetts General Hospital in 1995.
引用
收藏
页码:1565 / 1570
页数:6
相关论文
共 24 条
[1]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[2]  
BOYCE JM, 1995, INFECT CONT HOSP EP, V16, P634
[3]   CLONAL SPREAD OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BETWEEN PATIENTS IN 3 HOSPITALS IN 2 STATES [J].
CHOW, JW ;
KURITZA, A ;
SHLAES, DM ;
GREEN, M ;
SAHM, DF ;
ZERVOS, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (06) :1609-1611
[4]   CHARACTERIZATION OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI FROM UNITED-STATES HOSPITALS [J].
CLARK, NC ;
COOKSEY, RC ;
HILL, BC ;
SWENSON, JM ;
TENOVER, FC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2311-2317
[5]  
Dean AG, 1994, EPIINFO VERSION 6 WO
[6]   MOLECULAR TYPING OF AMPICILLIN-RESISTANT, NON-BETA-LACTAMASE-PRODUCING ENTEROCOCCUS-FAECIUM ISOLATES FROM DIVERSE GEOGRAPHIC AREAS [J].
DONABEDIAN, SM ;
CHOW, JW ;
BOYCE, JM ;
MCCABE, RE ;
MARKOWITZ, SM ;
COUDRON, PE ;
KURITZA, A ;
PIERSON, CL ;
ZERVOS, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2757-2761
[7]   THE VANA GLYCOPEPTIDE RESISTANCE PROTEIN IS RELATED TO D-ALANYL-D-ALANINE LIGASE CELL-WALL BIOSYNTHESIS ENZYMES [J].
DUTKAMALEN, S ;
MOLINAS, C ;
ARTHUR, M ;
COURVALIN, P .
MOLECULAR AND GENERAL GENETICS, 1990, 224 (03) :364-372
[8]   VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].
EDMOND, MB ;
OBER, JF ;
WEINBAUM, DL ;
PFALLER, MA ;
HWANG, T ;
SANFORD, MD ;
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133
[9]  
EDMOND MB, 1996, INFECT CONTROL HO S2, V17, P18
[10]   THE VANB GENE OF VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECALIS V583 IS STRUCTURALLY RELATED TO GENES ENCODING D-ALA D-ALA LIGASES AND GLYCOPEPTIDE-RESISTANCE PROTEINS VANA AND VANC [J].
EVERS, S ;
SAHM, DF ;
COURVALIN, P .
GENE, 1993, 124 (01) :143-144